Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Lipitor OTC Bid Would Face FDA Evolving On Switch Innovation

This article was originally published in The Tan Sheet

Executive Summary

Pfizer looks to lessons from prior statin attempts and an environment open to new ways to inform consumer decisions as it considers filing for a Lipitor switch, which will depend on the outcome of a large actual use trial.

Advertisement

Related Content

In Switch Label Studies, FDA Carefully Reads Data On Low-Literacy Consumers
In Switch Label Studies, FDA Carefully Reads Data On Low-Literacy Consumers
Petitions Denied For ‘Pharmacist Category’ Nonprescription Viagra, Lipitor, Chantix
Petitions Denied For ‘Pharmacist Category’ Nonprescription Viagra, Lipitor, Chantix
Rx Statin Critic Predicts Safer Use In Lower-Dose Switch OTCs
Rx Statin Critic Predicts Safer Use In Lower-Dose Switch OTCs
FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure
Statin Label Change Stirs OTC Switch Discussions
Pfizer Will Delay Lipitor Switch Until Rx Revenues Fade
FDA Advisors Say Greater Insight Needed On Self-Selection Of OTC Statins

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106782

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel